Publications by authors named "Mark R Looney"

Lung transplantation is still hindered by a high rate of chronic rejection necessitating profound immunosuppression with its associated complications. Donor-specific blood transfusion is a pre-transplant strategy aimed at improving graft acceptance. In contrast with standard stored blood or donor-specific regulatory T cells transfusions, this approach utilizes fresh whole blood from the donor prior to allograft transplantation, encompassing all cell types and plasma.

View Article and Find Full Text PDF
Article Synopsis
  • ARDS is a severe condition that leads to high rates of illness and death, with neutrophils playing a key role in its development.
  • Research shows that removing the Shp1 protein from neutrophils in mice leads to extreme inflammation and dangerous lung bleeding, suggesting that Shp1 helps regulate neutrophil activity.
  • The use of a Shp1 activator (SC43) may help control excessive neutrophil responses, presenting a potential treatment strategy for ARDS by reducing inflammation and associated lung damage.
View Article and Find Full Text PDF

Intravital microscopy has enabled the study of immune dynamics in the pulmonary microvasculature, but many key events remain unseen because they occur in deeper lung regions. We therefore developed a technique for stabilized intravital imaging of bronchovascular cuffs and collecting lymphatics surrounding pulmonary veins in mice. Intravital imaging of pulmonary lymphatics revealed ventilation-dependence of steady-state lung lymph flow and ventilation-independent lymph flow during inflammation.

View Article and Find Full Text PDF

Background: Pulmonary ischaemia-reperfusion injury (IRI) is a major contributor to poor lung transplant outcomes. We recently demonstrated a central role of airway-centred natural killer (NK) cells in mediating IRI; however, there are no existing effective therapies for directly targeting NK cells in humans.

Methods: We hypothesised that a depleting anti-CD94 monoclonal antibody (mAb) would provide therapeutic benefit in mouse and human models of IRI based on high levels of (CD94) transcripts in bronchoalveolar lavage samples from lung transplant patients.

View Article and Find Full Text PDF
Article Synopsis
  • SARS-CoV-2 primarily targets myeloid populations, particularly human alveolar macrophages, in the lungs, where ACE2 expression allows viral entry and infection.
  • The infection of these macrophages results in the production of more viruses while evading strong interferon responses, making it harder for the immune system to detect and combat the virus.
  • This hidden viral reservoir in lung myeloid cells during the early stages of infection facilitates viral growth and may contribute to immune-related complications.
View Article and Find Full Text PDF

Understanding how the host immune system engages complex pathogens is essential to developing therapeutic strategies to overcome their virulence. While granzymes are well understood to trigger apoptosis in infected host cells or bacteria, less is known about how the immune system mobilizes individual granzyme species to combat diverse pathogens. Toward the goal of studying individual granzyme function directly , we previously developed a new class of radiopharmaceuticals termed "restricted interaction peptides (RIPs)" that detect biochemically active endoproteases using positron emission tomography (PET).

View Article and Find Full Text PDF

Antibodies can initiate lung injury in a variety of disease states such as autoimmunity, in reactions to transfusions, or after organ transplantation, but the key factors determining in vivo pathogenicity of injury-inducing antibodies are unclear. Harmful antibodies often activate the complement cascade. A model for how IgG antibodies trigger complement activation involves interactions between IgG Fc domains driving the assembly of IgG hexamer structures that activate C1 complexes.

View Article and Find Full Text PDF

Antibodies can initiate lung injury in a variety of disease states such as autoimmunity, transfusion reactions, or after organ transplantation, but the key factors determining in vivo pathogenicity of injury-inducing antibodies are unclear. A previously overlooked step in complement activation by IgG antibodies has been elucidated involving interactions between IgG Fc domains that enable assembly of IgG hexamers, which can optimally activate the complement cascade. Here, we tested the in vivo relevance of IgG hexamers in a complement-dependent alloantibody model of acute lung injury.

View Article and Find Full Text PDF

The bone marrow is the main site of blood cell production in adults, however, rare pools of hematopoietic stem and progenitor cells with self-renewal and differentiation potential have been found in extramedullary organs. The lung is primarily known for its role in gas exchange but has recently been described as a site of blood production in mice. Here, we show that functional hematopoietic precursors reside in the extravascular spaces of the human lung, at a frequency similar to the bone marrow, and are capable of proliferation and engraftment.

View Article and Find Full Text PDF

Acute lung injury (ALI) carries a high risk of mortality but has no established pharmacologic therapy. We previously found that experimental ALI occurs through natural killer (NK) cell NKG2D receptor activation and that the cognate human ligand, MICB, was associated with ALI after transplantation. To investigate the association of a common missense variant, , with ALI.

View Article and Find Full Text PDF

Primary graft dysfunction (PGD) limits clinical benefit after lung transplantation, a life-prolonging therapy for patients with end-stage disease. PGD is the clinical syndrome resulting from pulmonary ischemia-reperfusion injury (IRI), driven by innate immune inflammation. We recently demonstrated a key role for NK cells in the airways of mouse models and human tissue samples of IRI.

View Article and Find Full Text PDF

Microbes, toxins, therapeutics, and cells are often instilled into lungs of mice to model diseases and test experimental interventions. Consistent pulmonary delivery is critical for experimental power and reproducibility, but we observed variation in outcomes between handlers using different anesthetic approaches for intranasal dosing in mice. We therefore used a radiotracer to quantify lung delivery after intranasal dosing under inhalational (isoflurane) versus injectable (ketamine/xylazine) anesthesia in C57BL/6 mice.

View Article and Find Full Text PDF
Article Synopsis
  • - Sepsis is a major cause of death in hospitals, but early diagnostics are inadequate; the IntelliSep test aims to improve this by assessing immune responses related to sepsis.
  • - The study tested how well the IntelliSep test correlates with biological markers connected to sepsis by experimenting with blood samples treated with PMA to induce NET formation and comparing ISI scores.
  • - Results showed that higher PMA concentrations led to significantly elevated ISI scores, and a linear correlation was found between ISI scores and levels of NET components in patient samples, suggesting IntelliSep could indicate sepsis-related changes.
View Article and Find Full Text PDF
Article Synopsis
  • The study explored how the airway epithelium responds to SARS-CoV-2 and its variants, using airway organoids from 20 different subjects to better understand infection mechanisms.* -
  • Tetraspanin-8 (TSPAN8) was identified as a key factor that enhances SARS-CoV-2 infection, working independently of the ACE2-Spike protein interaction.* -
  • Although Delta and Omicron variants showed lower infection rates than the original virus, they still altered the epithelial response, indicating potential new targets for COVID-19 treatments with TSPAN8-blocking antibodies.*
View Article and Find Full Text PDF

Microbes, toxins, therapeutics and cells are often instilled into lungs of mice to model diseases and test experimental interventions. Consistent pulmonary delivery is critical for experimental power and reproducibility, but we observed variation in outcomes between handlers using different anesthetic approaches for intranasal dosing into mice. We therefore used a radiotracer to quantify lung delivery after intranasal dosing under inhalational (isoflurane) versus injectable (ketamine/xylazine) anesthesia in C57BL/6 mice.

View Article and Find Full Text PDF
Article Synopsis
  • Lung transplantation can save lives for patients with serious lung diseases, but complications like primary graft dysfunction (PGD) limit outcomes.
  • A study analyzing samples from the first day after transplant found that certain immune indicators (NKG2D ligands) were linked to severe PGD and poorer recovery metrics.
  • The research suggests that targeting the immune response, specifically NKG2D receptors, could help manage PGD and improve patient outcomes.
View Article and Find Full Text PDF

Clinical and molecular heterogeneity are common features of human disease. Understanding the basis for heterogeneity has led to major advances in therapy for many cancers and pulmonary diseases such as cystic fibrosis and asthma. Although heterogeneity of risk factors, disease severity, and outcomes in survivors are common features of the acute respiratory distress syndrome (ARDS), many challenges exist in understanding the clinical and molecular basis for disease heterogeneity and using heterogeneity to tailor therapy for individual patients.

View Article and Find Full Text PDF
Article Synopsis
  • The study investigates how SARS-CoV-2, the virus responsible for COVID-19, enters human lung cells, with a special focus on how the immune system reacts to this infection.
  • Researchers developed a lung slice model to explore early viral pathogenesis and discovered that SARS-CoV-2 has a strong preference for infecting myeloid cells, such as alveolar macrophages, which differs from the immune response generated by infections of other viruses like Influenza A.
  • Findings showed that SARS-CoV-2 can replicate efficiently within myeloid cells while generating fewer immune responses, allowing the virus to thrive and evade the immune system early in the infection process.
View Article and Find Full Text PDF
Article Synopsis
  • The study examined how SARS-CoV-2 infects cells in the lungs, particularly focusing on myeloid cells, which are key components of the immune system.
  • Researchers created lung slice models to explore how this virus enters these cells and discovered that SARS-CoV-2 specifically targets myeloid populations, unlike the Influenza A virus.
  • The findings suggest that during early SARS-CoV-2 infection, myeloid cells can harbor the virus with limited immune response, facilitating viral growth and weakening the overall immune response.
View Article and Find Full Text PDF

Platelets have a wide range of functions including critical roles in hemostasis, thrombosis, and immunity. We hypothesized that during acute inflammation, such as in life-threatening sepsis, there are fundamental changes in the sites of platelet production and phenotypes of resultant platelets. Here, we showed during sepsis that the spleen was a major site of megakaryopoiesis and platelet production.

View Article and Find Full Text PDF

Rapid neutrophil recruitment to sites of inflammation is crucial for innate immune responses. Here, we reveal that the G-protein-coupled receptor GPR35 is upregulated in activated neutrophils, and it promotes their migration. GPR35-deficient neutrophils are less recruited from blood vessels into inflamed tissue, and the mice are less efficient in clearing peritoneal bacteria.

View Article and Find Full Text PDF
Article Synopsis
  • Dendritic cells (DCs), specifically type-2 conventional DCs (cDC2s), play a key role in starting adaptive immune responses, but how they are positioned and maintained in the spleen is not fully understood.
  • The study highlights that cDC2s rely on a protein called CD97, which requires a specific modification (autoproteolytic cleavage) for correct positioning within the spleen.
  • The interaction between cDC2s and red blood cells (RBCs) via CD55 under certain conditions leads to important changes in the DCs, and disruptions in this signaling pathway result in decreased cDC2s in the spleen and poorer immune responses to blood-borne pathogens.
View Article and Find Full Text PDF